BRD4 and ovarian carcinoma: Namely, across the entirety of the TCGA Pan-Cancer dataset, ovarian cancer patients have the highest rate of genetic amplifications at the BRD4 locus, with ~11% of patients having an amplification of this region (Fig. 1b)5–7,31.